Uncategorized Archives - Page 102 of 112

ThursdayMar 15, 2018 12:50 pm

PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Secures Australian Importation Permit in Support of Research into Sol-gels

Research will be conducted at PACE, a leading pharmaceutical research center in Australia PreveCeutical’s unique technology promises to be the first FDA-approved, CBD-based nose-to-brain delivery system using a Sol-gel platform Groundbreaking technology outstrips the benefits of any other delivery mechanism On March 13, 2018, PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) and Aurora Cannabis Inc. (OTCQB: ACBFF) (TSX: ACB) (FSE: 21P) announced that they had received three permits for the importation of cannabis plant material into Australia for research purposes. The permits were granted by the Australian Government’s Department of Health, allowing shipment from Canada by Aurora Cannabis…

WednesdayMar 14, 2018 12:12 pm

Global Hemp Group, Inc. (CSE: GHG) (FRA: GHG) (OTC: GBHPF) Completes $1.5 Million Private Placement

Proceeds to be used for development of new cultivation and processing project in New Brunswick A boost to operating capital Canada plans to legalize the extraction of cannabinoids from hemp in mid-2018 Market for hemp CBD products is predicted to grow to $450 million by 2020 Global Hemp Group, Inc. (CSE: GHG) (FRANKFURT: GHG) (OTC: GBHPF), a company focused on the cultivation of hemp and cannabinoid extraction for both domestic and international markets, announced on March 7, 2018, that it had closed a non-brokered private placement, consisting of 12.5 million units at a price of $0.12 per unit, to raise…

TuesdayMar 13, 2018 12:24 pm

Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) Finding Ever-Growing Ways to Administer Cannabis Benefits

Pivot Pharmaceuticals developing disruptive formulations for cannabis-infused markets Company’s goal is to strengthen dosage predictability and improve product stability Recent acquisitions and planned acquisitions give Pivot vertical position in multi-billion-dollar industries Despite recent setbacks to efforts seeking broader marijuana legalization in North America (http://cnw.fm/zM2Mc), the tide of social preferences for cannabis availability, even in recreational applications, continues to advance (http://cnw.fm/tT62e). Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) is helping to advance efforts to legitimize the drug’s use, both in medicinal and recreational settings, by pursuing ever-increasing methods for consuming cannabis’s derivatives in quantities with predictable outcomes. “Pivot’s goal…

MondayMar 12, 2018 4:13 pm

PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Linker Tech Mimics Body’s Production of Pain Relieving Peptides

Developing pain relievers that mimic body’s natural pain relief peptides Other programs include development of treatments for diabetes, synthetization of blue scorpion venom and study of a novel cannabinoid delivery platform Revenues from international licensing strategy The discovery of endomorphins in 1997 was a remarkable reminder of the human body’s wondrous nature. Endomorphins are naturally produced morphine-like substances with an affinity for the µ-opioid receptors in the brain, which fortunately happen to be the best places to alleviate pain. With a potency that far exceeds morphine, these endogenous substances are the body’s first line of defense against pain and stress.…

ThursdayMar 08, 2018 4:00 pm

Building a Portfolio of Industrial Hemp Companies is Key to the Future of Global Hemp Group, Inc. (CSE: GHG) (FRA: GHG) (OTC: GBHPF)

Global Hemp Group will employ joint ventures, partnerships, and acquisitions to capture cash flow, generate revenues and create value for its shareholders Global Hemp Group will be involved in the cultivation, processing and distribution of industrial hemp to domestic and international markets At the end of 2017, GHG issued its final report on the first year of its joint venture to produce industrial hemp on the Arcadian Peninsula of New Brunswick, Canada Global Hemp Group, Inc. (CSE: GHG) (FRANKFURT: GHG) (OTC: GBHPF) is focused on the vital role that industrial hemp will play in building a sustainable future. The company…

WednesdayMar 07, 2018 3:08 pm

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Enters Licensing Agreement with Cannabis Edibles Infusion Manufacturer

Lexaria enters agreement with Biolog for Lexaria’s DehydraTECH™ technology in return for royalties on sales revenue and licensing fees Biolog has exclusive rights to use the Lexaria technology for its particular applications for five years Lexaria is the only company worldwide with patent issued for oral delivery CBD and all other non-psychoactive cannabinoids Based in Kelowna, British Columbia, Lexaria Bioscience Corp. (OTCQX: LXRP) (CSE: LXX) announced on February 27, 2018, its entry into a technology licensing agreement with Biolog, Inc. for the provision of Lexaria’s patented DehydraTECH™ technology (http://cnw.fm/pY0oG). Lexaria’s proprietary technology will be used in the formulation of a…

WednesdayMar 07, 2018 1:21 pm

Cronos Group Inc. (NASDAQ: CRON) (TSX.V: MJN) is Building an International Brand Portfolio

Leading the industry forward as the first pure-play cannabis company to trade on the Nasdaq Canada set to legalize recreational cannabis Positioned for growth throughout the international medical marijuana market Cronos Group Inc. (NASDAQ: CRON) (TSX.V: MJN), a Toronto-based medical marijuana company, is the first pure-play cannabis company to trade on the Nasdaq. This transition has provided the company with legitimacy and enables investors to better assess CRON’s performance. Listing of CRON on the Nasdaq is a major move for the entire marijuana industry, according to The Motley Fool (http://cnw.fm/jL0b9). With cannabis deals this year already doubling the total for…

WednesdayMar 07, 2018 12:31 pm

Liberty Leaf Holdings Ltd. (CSE: LIB) (OTCQB: LIBFF) (FSE: HN3P) Continues to Capitalize on the Burgeoning Legal Marijuana Markets

Liberty subsidiary North Road Ventures inks new compliance agreement Agreement expands North Road’s existing business model Liberty’s diversified investment approach leverages opportunity in legal cannabis markets Liberty Leaf Holdings Ltd. (CSE: LIB) (OTCQB: LIBFF) (FSE: HN3P) continues to advance its business agenda to capitalize on the burgeoning legal marijuana markets. Liberty Leaf is in the business of acquiring partnership interests in up-and-coming and established companies in the medicinal and recreational cannabis space. The company currently operates in Canada and is actively seeking to enter all of the legal cannabis markets in North America. The recent signing of an agreement between…

TuesdayMar 06, 2018 2:39 pm

Cronos Group Inc. (NASDAQ: CRON) (TSX.V: MJN) Becomes First Canadian Cannabis Producer to be Traded on a Major US Exchange

Analysts call the listing a milestone for both Cronos Group and the entire cannabis industry Michael Gorenstein, CEO of Cronos Group, said that the company is the only ‘pure play’ marijuana company to be traded on a U.S. exchange Company has holdings or is involved in joint ventures in Canada, Germany, Israel and Australia Cronos Group Inc. (NASDAQ: CRON) (TSX.V: MJN), a Toronto-based medical marijuana company, recently began trading on the Nasdaq, uplisting from the Nasdaq International Designation program as an OTC stock to the Nasdaq Global Market and becoming the first Canadian cannabis producer stock to be listed on…

FridayMar 02, 2018 12:10 pm

Choom Holdings Inc. (CSE: CHOO) (OTCQB: CHOOF) Opens the Door for Canadian Entrepreneurs with Dispensary Rollout Strategy

Recreational marijuana set to be legalized in Canada in July 2018 Choom™ is developing unique lifestyle brand and national retail footprint in new $8.7 billion-plus market Retail rollout strategy provides entrepreneurs opportunity to profit from coming bonanza Entrepreneurs and businesspeople across Canada now have the opportunity to participate in the country’s lucrative new recreational marijuana market. Estimated to exceed $8.7 billion annually, recreational marijuana is set to be legalized in July of this year, and savvy business folks are looking for a piece of the cannabis pie. This is little wonder, since legal recreational marijuana dispensaries are expected generate more…

News and Publishing Service for Cannabis Related, Canadian Companies

Contact us: 512.354.7000

Category: Uncategorized